Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 452 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Closed				18 and over				Pharmaceutical / Industry				EU-HNBE-2003 NCT00198263


2.		Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Closed				18 and over				Pharmaceutical / Industry				EU-CCBE-2003 NCT00198276


3.		Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								DFCI-75100


4.		Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 65								WCCC-CO-7711R NCI-D80-048-183

Last Modified: 2/15/2006


5.		Phase II/III Master Protocol for Chemotherapy with DTIC/ACT-D vs CACP/VBL/BLEO vs Phase II Agent with or without Prophylactic Cranial Radiotherapy for Disseminated Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				SWOG-8107


6.		Phase II Chemotherapy with MTX/CF, Aminopterin or M-BACOD plus CTX or BCG Immunotherapy for Advanced non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				25 to 65								DFCI-75116


7.		Phase III Randomized Comparison of Combination Chemotherapy with BEP (BLEO/VP-16/CACP) for 9 Weeks vs 12 Weeks in Patients with Minimally or Moderately Disseminated Germ Cell Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								SEG-GU-306

Last Modified: 9/1/1988


8.		Phase II/III Induction Chemotherapy with CACP/BLEO/MTX/CF vs CACP/5-FU for Stage II/III/IV, Previously Untreated Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 09/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				DFCI-83084 NCI-T84-0282D, T84-0282

Last Modified: 6/23/2008


9.		Phase III Randomized Study of CDDP/IFF vs BIP (BLEO/IFF/CDDP) in Patients with Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				any age				NCI				GOG-149 GOG-0149

Last Modified: 10/1/2007 First Published: 4/1/1994


10.		Phase III Randomized Study of Radiotherapy With or Without Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Versus ABVD Only in Patients With Stage I-IIA Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 and over				Other				CAN-NCIC-HD6 E-JHD06, NCI-V94-0427, NCT00002561, HD6, JHD06

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute